Navigation Links
New method is found for accurate diagnosis of gall bladder cancer, 1 of the most deadly
Date:10/14/2010

This press release is available in Spanish.

Researchers a the University of Granada and the Department of Nuclear Medicine, Hospital Virgen de las Nieves at Granada found that the metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.

For the purpose of this study, 62 patients were subjected to this scanning method, which represents the largest sample of patients with gall bladder cancer ever studied by applying this type of technology called FDG positron emission tomography. The study reported excellent results, significantly better than other structural imaging methods, and enabled more accurate and appropriate diagnosis and treatment of patients, which allows to avoid unnecessary procedures.

This study was conducted by Sc.D Carlos Ramos Font and directed by professors Nicols Olea Serrano (UGR), Jos Manuel Llamas Elvira (UGR and Department of Nuclear Medicine, Hospital Virgen de las Nieves and Manuel Gmez Ro (Department of Nuclear Medicine, Hospital Virgen de las Nieves).

Early Diagnosis Is Essential

The high mortality rate among patients with gall bladder cancer depends heavily on the lack of clinical data enabling early diagnosis of this type of tumors. This fact determines the survival of this type of patients. At the moment of establishing a diagnosis, an accurate staging will allow to chose the most appropriate treatment, as well as to optimize the use of the resources available. Imaging diagnosis of this pathology is essentially based on morphological techniques (echography, X-ray computed tomography and magnetic resonance imaging).

This new imaging diagnosis method (tomography made by emission of positrons with 18F fluorodeoxyglucose) shows glucose metabolism in tissues. While the utility of this method has been proved in other types of tumors, its utility in gall bladder cancer had not been proved yet.

According to Granada University researchers, their study proves that positron emission tomography scanning wih FDG "is a valid and accurate method for precise staging of patients with suspected gall bladder cancer, which allows to determine the appropriate therapy and treatment, and to optimize the use of the resources available". Thus, they suggest that "each patient with suspected cancer should be subjected to this type of imaging diagnosis, to determine the nature of such process".


'/>"/>

Contact: Carlos Ramos Font
carlos.ramos.font.ext@juntadeandalucia.es
34-687-781-331
University of Granada
Source:Eurekalert  

Related medicine news :

1. Live with Regis and Kelly Reveal A REVOLUTIONARY Pain Relief Method
2. Two Surgical Methods Equally Successful for Prostate Cancer
3. Psychiatrys main method to prevent mistaken diagnoses of depression doesnt work: NYU study
4. New testing method hints at garlics cancer-fighting potential
5. MSU scientists develop more effective method of predicting lead-poisoning risk
6. Blood Draw Dilemma: New Summit Health Article Helps Employers Choose the Best Screening Method
7. Worlds most useful tree provides low-cost water purification method for developing world
8. FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs
9. Los Angeles Hair Transplant Cosmetic Surgeon Corrects Bad Hair Transplants With New Hair Restoration Method
10. An improved method for calculating tumor growth
11. New method to grow arteries could lead to biological bypass for heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New method is found for accurate diagnosis of gall bladder cancer, 1 of the most deadly
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the ... national TV host Tom Seay and his production crew. Tom Seay’s program “Best ... around the world. Saddle Sidekicks will be featured on April 6, 2017. After ...
(Date:2/22/2017)... ... 2017 , ... The Centers for Medicare & Medicaid Services ... Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate in the ... of 2015 (MACRA). , This technical assistance, authorized and funded under MACRA, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... 72 percent of those report that family members or friends have also commented ... suffer from hearing loss wear hearing aids. One reason, suggested by 89 percent ...
(Date:2/22/2017)... ... February 22, 2017 , ... FPS ... from combat-related PTSD. , Established in 1977, our organization was at the forefront ... military returning to civilian life were evident and served as the catalyst for ...
(Date:2/22/2017)... ... 22, 2017 , ... Apptricity® Corporation, a leading global provider ... today announced that Keppel Corporation has selected Apptricity Travel and Expense Management integrated ... are excited to announce the partnership between Keppel and Apptricity for our Global ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... -- Andre, DiMino, CEO of ADM Tronics Unlimited, Inc. (OTCQB: ... and products, commented on ADMT,s third quarter fiscal year ... the Company,s quarterly report on Form 10Q available at ... stated "During the quarter ended December 31, 2016 we ... portion of our engineering efforts into the development of ...
(Date:2/22/2017)... VANCOUVER, Feb. 22, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) ... for the quarter and full fiscal year ended December 31, ... ... the Company,s audited financial statements and management discussion and analysis ... have been filed on SEDAR and are available at ...
(Date:2/22/2017)... , Feb. 22, 2017 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... host its Fourth Quarter 2016 investor conference call and webcast ... The call will cover an update on Merrimack,s ... and full year 2016 financial results. A press release detailing ... issued the morning of Wednesday, March 1. Investors and the ...
Breaking Medicine Technology: